Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
put in the hospital after taking RSV; This serious case was reported by a consumer via interactive digital media and described the occurrence of hospitalization in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced hospitalization (Verbatim: put in the hospital after taking RSV) (serious criteria hospitalization). The outcome of the hospitalization was not reported. It was unknown if the reporter considered the hospitalization to be related to RSV vaccine. The company considered the hospitalization to be unrelated to RSV vaccine. Additional Information: GSK receipt date: 16-OCT-2025 This case was reported by a consumer via interactive digital media. The patient was hospitalized after taking RSV vaccine. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Hospitalization, unknown time after receiving RSV vaccine, in a patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.